로딩 중…
지수 로딩 중…
Nuvation Bio Inc.
NUVB· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$6.14-3.00%
2026-08-03
Financials
Valuation Metrics
Nuvation Bio Inc.'s Market Cap is $2.14B. At end of 2025 it was $3.09B. Ranked #2004 of 3,112 in US market (top 64%), #1247 of 1,667 on NYSE (top 75%), #127 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 47%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.14B | US#2,004/3,112 Sec#127/269 |
| Revenue | $143M | US#2,738/3,112 Sec#118/269 |
| Net Income | $-146M | US—/3,112 Sec—/269 |
| Total Assets | $610M | US#2,674/3,112 Sec#137/269 |
| Net Assets | $320M | US#2,516/3,112 Sec#153/269 |
| Value | ||
| P/B | 6.69x | US#2,390/3,112 Sec#169/269 |
| P/S | 14.95x | US#2,759/3,112 Sec#138/269 |
| FCF Yield | -5.90% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -45.69% | US#2,722/3,112 Sec#166/269 |
| ROA | -23.92% | US#2,818/3,112 Sec#140/269 |
| Op. Margin | -104.99% | US#2,826/3,112 Sec#125/269 |
| Revenue Growth | 2598.70% | US#16/3,112 Sec#7/269 |
| Financial Health | ||
| Debt Ratio | 90.96% | US#990/3,112 Sec#163/269 |
| Total Debt | $10M | US#2,786/3,112 Sec#197/269 |
| FCF | $-126M | US#2,636/3,112 Sec#169/269 |
| Cash | $125M | US#2,064/3,112 Sec#161/269 |
| Current Ratio | 7.44x | US#316/3,112 Sec#103/269 |
| Performance | ||
| 1Y Return | 175.34% | US#138/3,112 Sec#45/269 |
| 1M Return | 7.72% | US#699/3,112 Sec#30/269 |
| From 52W High | -37.03% | US#2,435/3,112 Sec#187/269 |
| 1Y MDD | -57.55% | US#2,665/3,112 Sec#208/269 |
| Trading | ||
| Volume | 4,714,385 shares | US#392/3,112 Sec#29/269 |
| Trading Value | $29M | US#1,745/3,112 Sec#121/269 |
| Per Share | ||
| EPS | $-0.59 | US—/3,112 Sec—/269 |
| BPS | $0.89 | US#2,635/3,112 Sec#206/269 |